A new faster technique restores vision in mice with retinal degeneration
National Institutes of Health (NIH) - 15-Apr-2020Researchers plan clinical trials of this in humans to treat retinal diseases
Join the club for FREE to access the whole archive and other member benefits.
CEO and president of CIRC Therapeutics and the Center for Retina Innovation
Sai Chavala, M.D., CEO and president of CIRC Therapeutics and the Center for Retina Innovation. Chavala is also director of retina services at KE Eye Centers of Texas and a professor of surgery at Texas Christian University and University of North Texas Health Science Center (UNTHSC) School of Medicine, Fort Worth.
Professor
Director, Laboratory for Retinal Rehabiliation (LORR)
Director, Translational Research
North Texas Eye Research Institute
University of North Texas Health Science Center
3500 Camp Bowie Blvd.
Fort Worth, TX 76107
sai.chavala@unthsc.edu
Telephone: 216-849-0437
Visit website: https://www.unthsc.edu/north-texas-eye-research-institute/nteri-labs/sai-chavala-md/
See also: CIRC THERAPEUTICS - Start-up company for eye treatments
Details last updated 16-Apr-2020
Researchers plan clinical trials of this in humans to treat retinal diseases